Integrative Gut–Hormone Optimization, Nutraceuticals, and Chiropractic Care

Abstract

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I walk you through how the gut microbiome, estrobolome, intestinal permeability, and autonomic balance shape hormone metabolism, immune signaling, thyroid health, and metabolic resilience. I translate the latest research into a practical, stepwise protocol that blends targeted nutrition and nutraceuticals (e.g., vitamin D3/K2/A, magnesium, methylated B vitamins, selenium, iodine, DIM, probiotics, fiber, L-glutamine, berberine, shilajit) with integrative chiropractic care to optimize motility, vagal tone, and neuroendocrine function. I explain how to optimize estrogen metabolism, boost free testosterone, support thyroid function in autoimmunity, and reduce LPS-driven inflammation associated with PCOS, endometriosis, and insulin resistance. Throughout, I share clinical observations from my practice and highlight peer-reviewed findings, so you can see how modern, evidence-based strategies become real-world results.

Why I Shifted From Symptoms To Systems

I used to pour immense effort into symptom-by-symptom relief. Many patients improved, but a subset plateaued—especially those with mixed neuroendocrine, metabolic, and musculoskeletal complaints. Over the last decade, my team and I focused on the gut–hormone–brain axis, the estrobolome (the gut–estrogen interface), and autonomic balance. When we treated the gut as a neuroendocrine-immune hub and paired it with chiropractic strategies that restore vagal tone and movement, patients recovered faster and more durably.

• What I saw repeatedly:
  • Constipation, bloating, and dysbiosis correlated with estrogen recirculation, PMS, acne, and cyclic pain.
  • Low-grade inflammation from lipopolysaccharides (LPS) worsened insulin resistance and PCOS.
  • Low vitamin D with suboptimal magnesium blunted hormone receptor responsiveness.
  • Thyroid autoimmunity improved when gut permeability, selenium, and oxidative balance were addressed.

The Gut Microbiome and Estrobolome: The Hormonal Relay You Cannot Ignore

The gut microbiome is a metabolic organ. Its metabolites and enzymes influence hormone signaling, bile acids, insulin sensitivity, and immune tone. Within it, the estrobolome—microbial genes that metabolize estrogens—helps determine whether conjugated estrogens are excreted or deconjugated and reabsorbed.

• Why this matters:
  • Beta-glucuronidase from certain bacteria deconjugates estrogens, increasing enterohepatic recycling and raising systemic exposure (Plottel & Blaser, 2011).
  • Dysbiosis elevates LPS levels, activating inflammatory pathways that impair insulin signaling and increase androgen excess, a core feature of PCOS (Sircana et al., 2019).
  • Short-chain fatty acids (SCFAs) like butyrate fuel colonocytes, reinforce tight junctions, and regulate immune tolerance (Koh et al., 2016).
• Key drivers that shape the microbiome:
  • Diet quality and fiber (especially fermentable forms)
  • Stress and sleep
  • Medications (antibiotics, PPIs, NSAIDs)
  • Alcohol and emulsifiers
  • Early-life exposures

In the clinic, women with fewer than 5–6 bowel movements per week often present with estrogen-dominant symptoms. Normalizing bowel transit is foundational for hormonal balance.

Dysbiosis Versus Leaky Gut: Different Problems, Vicious Cycle

• Dysbiosis: Loss of beneficial commensals and/or overgrowth of pathobionts, shifting bile acid pools, raising LPS, and reducing SCFAs (Halfvarson et al., 2017).
• Increased intestinal permeability (“leaky gut” ): Tight junction dysfunction (e.g., occludin, claudins), allowing antigens/endotoxin into circulation; influenced by zonulin, sugar/alcohol, emulsifiers, infections, cortisol, and injuries such as TBI.

These often co-occur:

• Dysbiosis ? more LPS ? inflammation ? tight junction disruption.
• Leaky junctions ? more antigen exposure ? immune activation ? further dysbiosis.

Clinical signals I track:

• Digestive: bloating, gas, constipation/loose stools, reflux
• Immune: recurrent sinusitis, atopy, dermatitis
• Hormonal: PMS, PCOS, fluid retention, severe cramps
• Autoimmune: Hashimoto’s, psoriasis, celiac spectrum
• Neurobehavioral: anxiety, low mood, sleep disruption
• Skin: acne, rosacea, eczema, seborrhea

Estrogen Metabolism And The Estrobolome: Steering Toward Safer Pathways

Estrogen metabolism involves:

• Phase I (CYP oxidation): Produces 2-, 4-, and 16?-hydroxy metabolites; 2-hydroxylation is generally less proliferative; 4-hydroxylation can create quinones with DNA adduct risks; 16?-hydroxy supports proliferative signaling (Ziegler et al., 2015).
• Phase II (conjugation): Methylation, glucuronidation, sulfation, and glutathione conjugation neutralize reactive metabolites for excretion.
• Enterohepatic circulation: Conjugated estrogens excreted into bile can be deconjugated by beta-glucuronidase and reabsorbed.

My clinical toolkit to bias safer pathways:

• DIM/I3C: Promote 2-hydroxylation; useful for estrogen-dominant symptoms and risk reduction (Reed et al., 2006).
• Methylated B vitamins (methylfolate, methylcobalamin, riboflavin, B6): Support methylation (COMT) and redox stability.
• Fiber + probiotics: Lower beta-glucuronidase activity and improve excretion (Wang et al., 2020).
• Daily bowel movements: Reduce recirculation; I prioritize hydration, magnesium, and fermentable fibers.

Vitamin D, K2, And A: Immune Modulation, Receptor Responsiveness, And Calcium Trafficking

Vitamin D acts as a hormone-like signal regulating immune tolerance, epithelial integrity, muscle function, and receptor biology (Carlberg & Haq, 2020). Clinically, suboptimal 25(OH)D levels correlate with reduced hormone responsiveness and increased cardiometabolic and autoimmune risks (Feldman et al., 2014). I commonly aim for 60–80 ng/mL, rechecking in 8–12 weeks.

• Why the D3/K2/A triad:
  • Vitamin D3 increases calcium absorption and modulates gene expression.
  • Vitamin K2 (MK-7) carboxylates osteocalcin and matrix Gla protein, directing calcium into bone and away from soft tissues.
  • Vitamin A (retinol) supports epithelial and immune health and complements calcium economy.

This synergy reduces the risk of ectopic calcification and supports endocrine function when D is repleted. I frequently pair D with magnesium, a required cofactor for vitamin D activation (Rosanoff et al., 2016).

Magnesium: The Silent Cofactor That Powers Vitamin D And Hormone Enzymes

Magnesium stabilizes ATP and is essential for kinase signaling, vitamin D activation (25- and 1?-hydroxylases), insulin signaling, and neuromuscular balance. Clinically, magnesium repletion improves sleep, reduces muscle tension, and helps relieve PMS symptoms. I use glycinate or citrate, titrated to bowel tolerance.

Chiropractic integration helps here: releasing diaphragmatic and lumbopelvic restrictions improves motility and autonomic regulation, which enhances mineral absorption and stress recovery.

Thyroid, Iodine, Selenium, And Zinc: Redox Balance First

The thyroid concentrates iodine to synthesize T4 and T3. Hormone production generates hydrogen peroxide (H2O2) within thyrocytes; selenium-dependent glutathione peroxidases and iodothyronine deiodinases are needed to detoxify peroxide and convert T4?T3.

• Key insights:
  • In autoimmune thyroiditis, the issue is often not iodine alone; it is insufficient selenium to neutralize H2O2, leading to thyrocyte damage and antigen spillage that fuel antibody production (Negro et al., 2007).
  • Iodine repletion should be paired with selenium (and often zinc) and introduced cautiously with gut-permeability repair to reduce antigen traffic.

Clinical approach:

• Start with balanced formulas (e.g., 200–400 mcg of iodine with 100–200 mcg of selenium and 10–30 mg of zinc) when indicated, and monitor TSH, free T4, free T3, and antibodies.
• Improve gut integrity and oxidative defense before up-titrating iodine.

Chiropractic support: cervicothoracic mobility and vagal tone practices can help autonomic balance and lymphatic drainage around the thyroid region, improving comfort and stress resilience.

DIM For Estrogen Risk Reduction And BRCA Pathways

Diindolylmethane (DIM) from crucifers helps steer estrogen metabolism toward 2-hydroxylation and away from 4- and 16?-pathways, supporting less proliferative signaling (Thompson et al., 2017). Emerging data suggest that DIM may upregulate BRCA1 expression and exert immunomodulatory effects, providing a mechanistic rationale for risk-reduction strategies in appropriate women.

• Dosing I often use:
  • Women at average risk: ~150 mg/day
  • Higher-risk women or survivors: ~300 mg/day
  • Men: 300–600 mg/day, tailored to risk and tolerance

I frequently pair DIM with omega-3s, methylated B vitamins, iodine (when appropriate), and selenium to support detoxification, redox balance, and gene expression.

Raising Free Testosterone Without Pushing Excessive Totals

In individuals, free testosterone (bioactive) often matters more than total. High SHBG can trap testosterone, leaving patients symptomatic despite “normal” totals.

How to improve free fractions:

• Reduce SHBG drivers: improve insulin sensitivity, reduce excessive estrogen via gut/liver support, correct hyperthyroid states if present, and ensure adequate protein and micronutrient intake.
• Support mitochondrial function and receptor sensitivity with nutrients like shilajit and magnesium.
• Optimize the gut–liver axis: probiotics, fiber, and diet reduce endotoxemia and inflammation that distort SHBG and steroidogenesis.

A case pattern from my clinic and personal tracking: keeping total testosterone steady while raising the free fraction correlates with better energy and recovery. Adding high-quality shilajit (fulvic acid–rich, 250 mg twice daily for ~90 days) has increased total and free testosterone and DHT in healthy men in randomized trials (Pandit et al., 2016). I use purified, third-party-tested products and monitor labs and symptoms.

PCOS, Endometriosis, And Autoimmune Thyroid Disease: A Gut-Driven Common Denominator

• PCOS: Dysbiosis and metabolic endotoxemia (LPS) elevate inflammation and worsen insulin resistance, elevating ovarian androgen production. Restoring SCFA-rich communities and lowering LPS improve ovulatory function and insulin sensitivity (Qi et al., 2019). Clinically, consistent fiber, probiotics, and improved transit reduce PMS, acne, and mid-cycle pain while improving glucose trends.
• Endometriosis: Altered microbiota, permeability, and estrogen recirculation can sustain lesion growth. Supporting the estrobolome through fiber, probiotics, and by reducing beta-glucuronidase activity may provide relief and lower flare frequency (Sanders et al., 2021).
• Autoimmune thyroid disease (Hashimoto’s/Graves’): Dysbiosis and barrier defects amplify antigen exposure and molecular mimicry. Restoring SCFAs and reducing intestinal inflammation are often associated with lower antibody titers and improved well-being, especially when vitamin D is optimized (Virili et al., 2018).

Integrative Chiropractic Care: Autonomics, Motility, And Neuroendocrine Balance

Chiropractic care in my integrative framework targets the autonomic nervous system, spinal reflex arcs, and movement—all of which influence gut motility, immune tone, and endocrine signaling.

• What I do and why:
  • Spinal adjustments: Decrease nociceptive drive and normalize segmental facilitation, particularly at thoracolumbar segments that influence sympathetic outflow to the GI tract; this can improve motility and reduce visceral pain.
  • Vagal tone practices: Cervical/suboccipital soft tissue work, slow nasal diaphragm breathing (4–6 breaths/min), humming/gargling, and graded cold exposure strengthen parasympathetic activity, supporting gastric secretion, peristalsis, and the anti-inflammatory reflex (Breit et al., 2018).
  • Graded movement therapy: Thoracic extension, hip–pelvis mobility, and dynamic stabilization enhance diaphragmatic excursion and lymphatic return, improving bowel regularity and tissue recovery.
  • Stress modulation: Micro-breaks, ergonomics, and sleep coaching reduce allostatic load, which otherwise disrupts tight junctions and HPA axis balance.

In my clinics, combining chiropractic care with fiber, probiotics, and vitamin D optimization accelerates normalization of bowel patterns, reduces PMS pain, lowers skin flares, and steadies mood across cycles.

Building A Practical, Stepwise Protocol Patients Can Sustain

I avoid overwhelming patients on day one. I stack interventions to match readiness and capacity:

1. Assess and stabilize
   • Ensure daily bowel movements; if not, prioritize hydration, magnesium (glycinate or citrate), and soluble fermentable fiber.
   • Baseline labs: 25(OH)D, fasting glucose/insulin (or HOMA-IR), hs-CRP, thyroid panel (with antibodies if indicated).
   • Begin vitamin D3 repletion with K2 and magnesium; retest at 8–12 weeks.
2. Reduce inflammatory load
   • Diet: “Avoid eating out of packages.” Choose products with fewer than five pronounceable ingredients.
   • Staples: extra-virgin olive oil, fatty fish, berries, cruciferous vegetables, legumes (if tolerated).
   • Alcohol: Set realistic ceilings and alcohol-free days to lower permeability.
3. Rebuild microbiome and barrier
   • Prebiotic fiber: Partially hydrolyzed guar gum (PHGG) 4–6 g/day to grow butyrate producers.
   • Probiotics: Lactobacillus and Bifidobacterium strains; rotate or blend; titrate to tolerance.
   • L-glutamine: ~5 g/day for enterocyte fuel and tight junction support.
   • Berberine: 300–500 mg with meals 1–2 times daily for 8–12 weeks for metabolic-endotoxin–heavy profiles; monitor for interactions.
4. Optimize estrogen metabolism (if estrogen-dominant or on HRT)
   • DIM/I3C to bias 2-hydroxylation.
   • Methylated B complex to support methylation.
   • Maintain transit to minimize enterohepatic recirculation.
5. Thyroid-immune calibration (when indicated)
   • Iodine + selenium + zinc, layered after gut and antioxidant support.
   • Consider NAC or liposomal glutathione for redox reinforcement.
   • Monitor TSH, free T4, free T3, and antibodies; reassess at 8–12 weeks.
6. Androgen optimization without excess totals
   • Improve insulin sensitivity, lower SHBG drivers, and support mitochondria.
   • Consider shilajit (purified, 250 mg twice daily for ~90 days) in appropriate patients; re-check total/free testosterone and SHBG.
   • Use chiropractic care to lower nociception and sympathetic load that antagonize gonadal axes.
7. Integrative chiropractic and autonomics
   • Weekly to biweekly initially: adjustments, soft tissue, breath training.
   • Home: 5 minutes diaphragmatic breathing twice daily, 10–15 minutes brisk post-meal walks, light thoracic mobility.
8. Reassess and personalize
   • Retest vitamin D and adjust.
   • If estrogen-dominant symptoms persist, consider testing urinary estrogen metabolites.
   • Escalate to advanced stool testing or SIBO assessment if GI symptoms remain.

Why Each Technique Works: Physiological Rationale

• PHGG fiber: Feeds butyrate producers (Faecalibacterium, Roseburia), fuels colonocytes, improves tight junctions, and speeds transit to limit estrogen recirculation and LPS exposure (Koh et al., 2016).
• Probiotics: Competitive exclusion of pathobionts; some strains reduce beta-glucuronidase and upregulate mucins and tight junction proteins; modulate bile acids and dampen inflammatory signaling (Suez et al., 2019).
• L-glutamine: Primary fuel for enterocytes and immune cells; stabilizes tight junctions and reduces permeability under stress (Rao & Samak, 2012).
• Berberine: Activates AMPK, improving insulin sensitivity; antimicrobial effects rebalance dysbiosis; modulates FXR/TGR5 via bile acids for glucose and lipid metabolism (Cicero & Baggioni, 2016).
• DIM/I3C: Induce CYP1A1 and favor 2-hydroxylation of estrogens, reducing proliferative metabolite load (Reed et al., 2006; Thompson et al., 2017).
• Methylated B vitamins: Support COMT and methylation pathways to neutralize catechol estrogens; riboflavin supports MTHFR; B6 aids transsulfuration and neurotransmitter balance (Obeid, 2013).
• Vitamin D: VDR signaling maintains tight junctions, enhances Treg function, and bolsters antimicrobial peptides; supports muscle-bone health and receptor responsiveness (Carlberg & Haq, 2020).
• Magnesium: Required for vitamin D activation, ATP-dependent enzymes, insulin signaling, and neuromuscular regulation (Rosanoff et al., 2016).
• Iodine + selenium + zinc: Enable thyroid hormone synthesis and detoxification of H2O2, protect thyrocytes, and support T4?T3 conversion; zinc also supports steroid receptor function.
• Shilajit: Fulvic acids enhance mitochondrial function, mineral transport, and endocrine signaling; clinical trial data show increased total and free testosterone and DHT in healthy men (Pandit et al., 2016).
• Chiropractic adjustments and vagal practices: Normalize sympathetic/parasympathetic balance, improving gastric secretion, peristalsis, and anti-inflammatory reflexes; lessen nociception to relieve HPA strain (Breit et al., 2018).

Real-World Coaching: One Lever At A Time

Front-loading everything usually fails. I start with one lever that patients can feel within 2–4 weeks—often vitamin D repletion with magnesium plus PHGG. As energy, sleep, and bowel regularity improve, I add a probiotic and L-glutamine, then DIM and a methylated B complex if estrogen-dominant symptoms persist. Wins build momentum. Patients then embrace diet upgrades, movement, and breath routines.

Patterns I observe and document on my platforms:

• As vitamin D rises into the 60–80 ng/mL window and gut protocols take hold, hormone therapies “start working again,” PMS eases, skin calms, and bloating diminishes.
• In Hashimoto’s, improving gut integrity and selenium status, while judiciously introducing iodine, can be associated with lower antibody titers and better energy levels.
• Young men avoiding exogenous testosterone can regain vigor with shilajit, methylated B vitamins, and lifestyle alignment—especially when we focus on the free fraction and on lowering SHBG drivers.

Putting It All Together: An Integrative Roadmap You Can Follow

• Evaluate gut and hormone dynamics first (bowel habits, symptom clusters, vitamin D, basic labs).
• Prioritize bowel regularity and inflammatory load reduction before layering specialty nutraceuticals.
• Use fiber + probiotic + L-glutamine as a foundational gut repair.
• Add DIM/I3C and methylated B vitamins to direct estrogen metabolism when indicated.
• Normalize vitamin D to 60–80 ng/mL with K2 and magnesium to support receptor responsiveness and immune balance.
• Consider iodine, selenium, and zinc for thyroid support when appropriate, with redox and gut integrity in place.
• Improve free testosterone via SHBG management, mitochondria support, and, when indicated, shilajit—not by indiscriminately pushing totals.
• Integrate chiropractic care to optimize autonomic tone, movement, and stress physiology.
• Reassess and personalize; escalate testing only as needed.

By anchoring care in physiology and sequencing interventions in a patient-friendly way, we consistently see durable improvements in endocrine symptoms, gut comfort, metabolic markers, and overall resilience.

References

• Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018). Vagus nerve as modulator of the brain–gut axis in psychiatric and inflammatory disorders. Trends in Neurosciences, 41(9), 577–589.
• Carlberg, C., & Haq, A. (2020). The concept of the personal vitamin D response index. Nutrients, 12(12), 3621.
• Cicero, A. F. G., & Baggioni, A. (2016). Berberine and its role in chronic disease. Evidence-Based Complementary and Alternative Medicine, 2016, 1–17.
• Feldman, D., Krishnan, A. V., Swami, S., Giovannucci, E., & Feldman, B. J. (2014). The role of vitamin D in reducing cancer risk and progression. Nature Reviews Cancer, 14(5), 342–357.
• Halfvarson, J., et al. (2017). Dynamics of the human gut microbiome in inflammatory bowel disease. Nature Biotechnology, 35, 833–839.
• Kho, Z. Y., & Lal, S. K. (2018). The human gut microbiome – a potential controller of wellness and disease. Frontiers in Microbiology, 9, 1835.
• Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell, 165(6), 1332–1345.
• Negro, R., et al. (2007). Selenium supplementation in autoimmune thyroiditis. The Journal of Clinical Endocrinology & Metabolism, 92(4), 1679–1684.
• Obeid, R. (2013). The metabolic burden of methyl donor deficiency with focus on the betaine pathway. Molecular Nutrition & Food Research, 57(4), 1–13.
• Pandit, S., et al. (2016). Clinical evaluation of purified shilajit. Andrologia, 48(5), 570–578.
• Plottel, C. S., & Blaser, M. J. (2011). Microbiome and malignancy. Nature Reviews Cancer, 11, 905–914.
• Qi, X., Yun, C., Sun, L., et al. (2019). Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome. Nature Medicine, 25, 1225–1233.
• Rao, R. K., & Samak, G. (2012). Role of glutamine in protection of intestinal epithelial tight junctions. The Scientific World Journal, 2012, 1–8.
• Reed, G. A., et al. (2006). Single-dose and multiple-dose administration of indole-3-carbinol and absorption and excretion in humans. Cancer Epidemiology, Biomarkers & Prevention, 15(12), 2477–2481.
• Rosanoff, A., et al. (2016). Magnesium and the vitamin D metabolism. Nutrition Research, 36(4), 279–289.
• Sanders, M. E., et al. (2021). The microbiome and women’s health. Frontiers in Microbiology, 12, 655233.
• Sircana, A., et al. (2019). Gut microbiota, obesity, and insulin resistance: an updated mini-review. Nutrients, 11(1), 35.
• Suez, J., Zmora, N., Segal, E., & Elinav, E. (2019). The pros, cons, and many unknowns of probiotics. Nature Reviews Microbiology, 17, 1–14.
• Thompson, H. J., et al. (2017). BRCA1, estrogen metabolism, and chemoprevention by dietary indoles. Molecular Nutrition & Food Research, 61(6), 1600789.
• Virili, C., et al. (2018). Gut microbiota and Hashimoto’s thyroiditis. Nutrients, 10(3), 283.
• Wang, Y., et al. (2020). Dietary fiber and gut microbiota in human health. Nature Reviews Microbiology, 18, 1–15.
• Ziegler, R. G., et al. (2015). Estrogens and the pathway of estrogen metabolism. Annual Review of Nutrition, 35, 285–299.